Clinical Trial: A Multi-omics and Artificial Intelligence Approach to Molecular Subtyping and Regulatory Mechanisms of Intervertebral Disc Degeneration (China)

China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multi-omics and Artificial Intelligence Approach to Molecular Subtyping and Regulatory Mechanisms of Intervertebral Disc Degeneration'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131844

Registration Time: 2026/09/07

Type: Observational study

Primary Sponsor: Army Medical Center of PLA

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341205

Published by HT Digital Content Services with permission from Health Daily Digest....